List of Fungal Infections for the First Time: WHO

The World Health Organization just published the first-ever Priority Pathogens list of fungi that can endanger public health.

What is the WHO's Priority Pathogen List for Fungi?

• FPPL: The top 19 fungi that pose the greatest risk to human health are listed on the Fungal Priority Pathogens List (FPPL).
• The list is based on the bacterial priority pathogens list, which was first created by WHO in 2017 with a similar goal of mobilising attention and action on a worldwide scale.
• Its goal is to direct and encourage additional study and policy changes to improve the world's response to fungus diseases and antifungal resistance.

Categories:

• The pathogen's effect on public health or the danger of emerging antifungal resistance are used to classify the infection.
• Candida auris, a highly drug-resistant fungus, Cryptococcus neoformans, Aspergillus fumigatus, and Candida albicans are all included in this critical priority group.
• High Priority Group: This group consists of several different fungi from the Candida family as well as others like Mucorales, a group that contains "black fungus," an illness that rapidly increased in very ill persons during COVID-19, notably in India.
• Other fungi in this Medium Priority Group include Cryptococcus gattii and Coccidioides spp.

Recommendations from the FPPL Report

• enhancing the capability and oversight of laboratories.
• maintaining financial commitments to innovation, research, and development.
• enhancing preventative and control strategies in public health.

What are the Emerging Issues with Fungal Pathogens?

Concerns:

• Only four types of antifungal medications are now on the market, and there aren't many candidates in the clinical development stage, making fungal diseases a serious concern to public health. They are also getting more prevalent and resistant to treatment.
• Rapid and accurate diagnostics are rare for fungal diseases, and those that do exist are either expensive or not generally accessible worldwide.
• A growing body of research suggests that global warming, an increase in international travel, and increased trade are all contributing to a rise in both the prevalence and geographic range of fungal illnesses.
• The reported incidence of invasive fungal infections among hospitalised patients increased considerably during the COVID-19 pandemic.
• Risks for the emergence of more invasive forms of diseases in the general population are rising along with the resistance of the fungi that cause common infections (such candida oral and vaginal thrush) to treatment.

Target audience

• Patients with severe illnesses and those who have serious underlying immune system-related problems are frequently affected by these fungus infections.
• Those with cancer, HIV/AIDS, organ transplants, chronic respiratory diseases, and post-primary tuberculosis infection are among the populations most at risk for invasive fungal infections.